PBMT for the Management of CIA ( HAIRLASER )

  • End date
    Dec 31, 2022
  • participants needed
  • sponsor
    Hasselt University
Updated on 8 April 2022
breast cancer
treatment regimen
breast adenocarcinoma
scalp cooling


Chemotherapy (CT) remains an important treatment modality for breast cancer patients. Unfortunately, this systemic treatment comes with many quality of life impairing complications. Chemotherapy-induced alopecia (CIA) occurs in about 65% of the patients. Hair loss due to CT is reversible, but hair regrowth requires several months to a year after CT. Currently, the only available preventive measure is based on scalp cooling. Nevertheless, this treatment has a highly variable success rate and it brings along several side effects. Photobiomodulation therapy (PBMT) is a new, preventive and therapeutic technique in the supportive care of cancer patients. It uses visible and (near)- infrared light produced by laser diodes or light-emitting diodes (LED) at a low power to stimulate tissue repair and reduce inflammation and pain. The investigator's research team demonstrated already that PBMT can prevent oral mucositis and acute radiodermatitis. The aim of this project is to explore the use of PBMT in the management of CIA. Results of this project will lead to an improvement of the patients' quality of life after CT.

Condition Breast Cancer, Chemotherapy-induced Alopecia, Alopecia
Treatment Photobiomodulation Therapy, Sham photobiomodulation therapy
Clinical Study IdentifierNCT04036994
SponsorHasselt University
Last Modified on8 April 2022


Yes No Not Sure

Inclusion Criteria

Informed Consent as documented by signature
Age 18 years or above
Use of a wig for at least 2 hours a day
Able to read and converse in Dutch
Skin type I to IV on the Fitzpatrick Skin Type Scale
Diagnosis of non-invasive (stage 0) or invasive (stage 1, 2 and 3A) breast adenocarcinoma
Treatment with neoadjuvant (preoperative) or adjuvant (postoperative) chemotherapy: anthracycline and taxane containing (paclitaxel or docetaxel) chemotherapy regimen
Diagnosed with CIA grade 2 according to Common Terminology Criteria for Adverse Events (CTCAE)
Have no documented or observable psychiatric or neurological disorders that might interfere with study participation (e.g., dementia or psychosis)

Exclusion Criteria

Metastatic disease
Severe or unstable cardio- respiratory or musculoskeletal disease
Presence of cognitive impairment that might impact study outcomes
Previously (before start of chemotherapy) diagnosed with a hair loss condition
Receiving scalp cooling during chemotherapy
Take any of the following medications for 6 months prior to initiation of the study: minoxidil, finasteride (or any other 5α-reductase inhibitor medications), medications with anti-androgenic properties (e.g. cyproterone, spironolactone, ketoconazole, flutamide and bicalutamide)n medications that can potentially cause hypertrichosis (ciclosporin, diazoxide, phenytoin and psoralens), and oral glucocorticoids
Active infection on the scalp
Chronic dermatologic condition (e.g. eczema, psoriasis, infection)
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact



Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note